[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100397700":3},{"organization":4,"armGroups":7,"interventions":27,"overallOfficials":42,"centralContacts":46,"locations":53,"responsibleParty":84,"collaborators":86,"id":90,"slug":91,"hasResults":92,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":32,"eligibilityCriteria":96,"healthyVolunteers":92,"sex":97,"minAge":98,"maxAge":99,"enrollmentInfo":100,"targetDuration":32,"studyType":103,"phases":104,"briefSummary":106,"conditions":107,"keywords":109,"overallStatus":56,"whyStopped":32,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":122},{"fullName":5,"class":6},"Memorial Sloan Kettering Cancer Center","OTHER",[8,14,18,22],{"label":9,"type":10,"description":11,"interventionNames":12},"(A) breast cancer after completion of chemo","EXPERIMENTAL","300 min\u002Fwk for 16 weeks, followed by 16 weeks of usual care.",[13],"Other: Aerobic Training",{"label":15,"type":10,"description":16,"interventionNames":17},"(B) breast cancer after completion of chemo","150 min\u002Fwk for 32 weeks.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"(C) breast cancer after completion of chemo","300 min\u002Fwk for 32 weeks.",[13],{"label":23,"type":24,"description":25,"interventionNames":26},"(D) breast cancer after completion of chemo","ACTIVE_COMPARATOR","150 min\u002Fwk for 16 weeks, followed by 16 weeks of usual care.",[13],[28,33,36,39],{"type":6,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"Aerobic Training","300 min\u002Fwk for 16 weeks",[9],null,{"type":6,"name":29,"description":34,"armGroupLabels":35,"otherNames":32},"150 min\u002Fwk for 32 weeks",[15],{"type":6,"name":29,"description":37,"armGroupLabels":38,"otherNames":32},"300 min\u002Fwk for 32 weeks",[19],{"type":6,"name":29,"description":40,"armGroupLabels":41,"otherNames":32},"150 min\u002Fwk for 16 weeks",[23],[43],{"name":44,"affiliation":5,"role":45},"Jessica Scott, PhD","PRINCIPAL_INVESTIGATOR",[47,51],{"name":44,"role":48,"phone":49,"phoneExt":32,"email":50},"CONTACT","646-888-8103","scottj1@mskcc.org",{"name":52,"role":48,"phone":49,"phoneExt":32,"email":32},"Lee Jones, PhD",[54,72],{"facility":55,"status":56,"city":57,"state":58,"zip":59,"country":60,"countryCode":61,"cosmosGeoPoint":62,"geoPoint":67,"contacts":68},"Hartford Healthcare Cancer Institute @ Hartford Hospital (Data Collection Only)","RECRUITING","Hartford","Connecticut","06102","United States","US",{"type":63,"coordinates":64},"Point",[65,66],-72.68509,41.76371,{"lat":66,"lon":65},[69],{"name":70,"role":48,"phone":71,"phoneExt":32,"email":32},"Andrew Salner, MD","860-972-2803",{"facility":5,"status":56,"city":73,"state":73,"zip":74,"country":60,"countryCode":61,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"New York","10065",{"type":63,"coordinates":76},[77,78],-74.00597,40.71427,{"lat":78,"lon":77},[81,82,83],{"name":44,"role":48,"phone":49,"phoneExt":32,"email":32},{"name":52,"role":48,"phone":49,"phoneExt":32,"email":32},{"name":44,"role":45,"phone":32,"phoneExt":32,"email":32},{"type":85,"investigatorFullName":32,"investigatorTitle":32,"investigatorAffiliation":32,"oldNameTitle":32,"oldOrganization":32},"SPONSOR",[87],{"name":88,"class":89},"National Cancer Institute (NCI)","NIH","100397700","exercise-therapy-to-improve-cardiovascular-health-in-post-menopausal-women-after-treatment-for-early-stage-breast-cancer-100397700",false,"NCT04458532","Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer","A Randomized Trial to Minimize Non-Response to Aerobic Training in Post-Menopausal Women With Early Stage Breast Cancer","Inclusion Criteria:\n\n* Aged 21-80 years\n* Female\n* Surgically resected early stage (I-III) primary breast cancer\n* Post-menopausal, defined as one of the following:\n\n  * Age ≥ 45 with no menses for at least 2 years\n  * Chemically and\u002For surgically induced menopause through ovarian suppression, as determined by the primary oncologist\n  * Estradiol level of ≤30 pg\u002FmL\n* An interval of at least one year, but no more than five years, following the full completion of definitive therapy for malignant disease. Definitive therapy is defined as:\n\n  * Surgery plus radiation\n  * Surgery plus chemotherapy\n  * Surgery plus trastuzumab\n* Exercise intolerance (i.e., patients must have a VO2peak below the predicted for active age and sex-matched individuals. (+\u002F- the technical error of 1.32 mL\u002Fkg\u002Fmin)\\].\n\nNote: Normative values are available up to 80 years of age)\n\n* Able to complete an acceptable baseline CPET, in the absence of high-risk ECG findings or other inappropriate response to exercise as determined by the PI, as defined by any of the following criteria:\n\n  * Achieving a plateau in oxygen consumption, concurrent with an increase in power output;\n  * A respiratory exchange ratio ≥ 1.10;\n  * Attainment of maximal predicted heart rate (HRmax) (i.e., within 10 bpm of age-predicted HRmax \\[HRmax = 220-Age\\[years\\]);\n  * Volitional exhaustion, as measured by a rating of perceived exertion (RPE) ≥ 18 on the BORG scale\n* Willingness to comply with all study-related procedures.\n\nExclusion Criteria:\n\n* Any of the following absolute contraindications to cardiopulmonary exercise testing:\n\n  * Acute myocardial infarction within 3-5 days of any planned study procedures\n  * Unstable angina\n  * Uncontrolled arrhythmia causing symptoms or hemodynamic compromise\n  * Recurrent syncope\n  * Active endocarditis\n  * Acute myocarditis or pericarditis\n  * Symptomatic severe aortic stenosis\n  * Uncontrolled heart failure\n  * Acute pulmonary embolus or pulmonary infarction within 3 months of any planned study procedures\n  * Thrombosis of lower extremities\n  * Suspected dissecting aneurysm\n  * Uncontrolled asthma\n  * Pulmonary edema\n  * Respiratory failure\n  * Acute non-cardiopulmonary disorders that may affect exercise performance or be aggravated by exercise (e.g., infection, renal failure, thyrotoxicosis)\n* Presence of any other concurrent, actively treated malignancy\n* History of any other malignancy treated within the past 3 years (other than non-melanoma skin cancer)\n* Presence of distant metastatic disease (i.e., stage IV)\n* Room air desaturation at rest ≤ 85%\n* Mental impairment leading to inability to cooperate.\n* Any other condition or intercurrent illness that, in the opinion of the investigator, makes the participant a poor candidate for the trial.","FEMALE","21 Years","80 Years",{"count":101,"type":102},152,"ESTIMATED","INTERVENTIONAL",[105],"NA","This study will compare the effects on cardiorespiratory fitness (CRF) of aerobic exercise in different amounts (number of minutes\u002Fsession) over different periods of time (number of weeks). Aerobic exercise is physical activity of light-to-moderate intensity that uses the large muscle groups (muscles in your legs, buttocks, back, and chest) and can be performed for at least 10 minutes.\n\nThe researchers will study the effects of different exercise programs on how well the study participants' bodies use oxygen, how well their heart pumps blood, how well their lungs function, and how healthy their blood vessels are.",[108],"Early Stage Breast Cancer",[110,29,111,112],"Exercise Therapy","Post-Menopausal Women","20-130","2026-03-24",{"date":115,"type":116},"2026-03-25","ACTUAL",{"date":118,"type":116},"2020-10-08",{"date":120,"type":102},"2027-03-31",{"name":5,"class":6},2]